International Stem Cell (ISCO) Other Non-Current Liabilities (2011 - 2020)

International Stem Cell (ISCO) has reported Other Non-Current Liabilities for 9 consecutive years, with $40000.0 the latest figure, recorded in Q3 2020.

• On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $40000.0 in Q3 2020; TTM through Sep 2020 was $40000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $207000.0, down 88.14% from the prior year.
• Other Non-Current Liabilities was $40000.0 for Q3 2020 at International Stem Cell, down from $322000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $19.6 million in Q1 2016 and troughed at $40000.0 in Q3 2020.
• A 5-year average of $3.3 million and a median of $2.3 million in 2016 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities jumped 755.65% in 2016 and sank 91.55% in 2020, its largest moves.
• Over 5 years, Other Non-Current Liabilities stood at $2.0 million in 2016, then surged by 52.22% to $3.1 million in 2017, then slumped by 43.94% to $1.7 million in 2018, then slumped by 88.14% to $207000.0 in 2019, then slumped by 80.68% to $40000.0 in 2020.
• The last three Other Non-Current Liabilities figures came in at $40000.0 (Q3 2020), $322000.0 (Q2 2020), and $97000.0 (Q1 2020), per Business Quant data.